etrials EDC to Interface with Green Mountain Logic LabPas CT(TM)
MONTPELIER, Vt. & MORISSVILLE, N.C., Jul 24, 2007 (BUSINESS WIRE) —
An agreement to create an interface between etrials’ Electronic Data Capture (EDC), most adaptable, flexible and advanced eClinical solution on the market today, and LabPas CT, the leading Phase I automation software developed by Green Mountain Logic (GML), was announced today by the two companies.
The interface provides a complete end-to-end solution for Phase I clinical research and shortens overall trial times while also improving data quality. LabPas CT, a full enterprise solution for the conduct of Phase I clinical trials, will automate key clinical trial data collection, make trial data available in real-time and electronically export validated data to etrials’ EDC. etrials’ EDC will provide a web-based, globally-proven solution for collecting, managing and analyzing real-time clinical trial information.
“Both etrials EDC and LabPas CT are highly regarded for their innovative, flexible and sophisticated, yet easy-to-use technology,” said John Rosenblum, CEO, GML. “The synergy between these solutions is extraordinary.”
“etrials’ partnership with GML is a great example of our joint commitment to helping clients’ accelerate their time-to-market,” Chip Jennings, president and CEO of etrials. “The integration of etrials EDC and LabPas CT demonstrates our companies’ deep understanding of our clients’ real-world challenges. The level of automation this technology interface provides can go a long way to streamlining Phase I clinical trials.”
About Green Mountain Logic and LabPas CT
Green Mountain Logic, located in Montpelier, Vermont, provides powerful, reliable, easy to use, targeted technology solutions to the life science industry. GML’s LabPas CT product comprehensively manages Phase I clinical trials, from recruiting through export to EDC. Unique in its intuitive use and adaptability to individual study protocols, LabPas CT increases margins, improves compliance and expands capabilities. In the last year, seven highly regarded CROs have selected LabPas CT to automate their Phase I studies. Additional information about LabPas CT is available at www.labpas.com.
About etrials Worldwide
etrials Worldwide, Inc. (Nasdaq: ETWC, ETWCW, ETWCU), a leading provider of eClinical software and services to pharmaceutical, biotechnology, medical device, and contract research organizations offers insight into all aspects of clinical trials, maximizing return on investment and accelerating time to market. With global operations, etrials is the only top-tier solutions provider to offer electronic data capture (EDC), interactive voice response (IVR), and electronic patient diaries (eDiary) as part of an integrated software as a service (SaaS) platform or as individual solutions to optimize clinical trials. As an experienced leader, etrials has facilitated over 900 trials involving more than 400,000 patients in 60 countries and has participated in 33 studies used for new drug applications. Having partnered with over 100 clients, including 16 of the top 20 global pharmaceutical companies and top CROs, etrials is leading the way toward adaptive trials and integration between eClinical and electronic health records. To learn more visit us at www.etrials.com.
